AR118999A1 - Moléculas de unión anti-tdp-43 y usos de las mismas - Google Patents

Moléculas de unión anti-tdp-43 y usos de las mismas

Info

Publication number
AR118999A1
AR118999A1 ARP200101467A ARP200101467A AR118999A1 AR 118999 A1 AR118999 A1 AR 118999A1 AR P200101467 A ARP200101467 A AR P200101467A AR P200101467 A ARP200101467 A AR P200101467A AR 118999 A1 AR118999 A1 AR 118999A1
Authority
AR
Argentina
Prior art keywords
tdp
disease
encephalopathy
binding molecules
tardb
Prior art date
Application number
ARP200101467A
Other languages
English (en)
Inventor
Tamara Seredenina
Tamar Magdalena Ziehm
Tariq Afroz
Original Assignee
Ac Immune Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ac Immune Sa filed Critical Ac Immune Sa
Publication of AR118999A1 publication Critical patent/AR118999A1/es

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

Proteínas de unión a ADN de respuesta transactiva con un peso molecular de 43 kDa (TARDB o también TDP-43). Se describen moléculas de unión específicas de TDP-43, en particular con anticuerpos antiTDP-43 o un fragmento de unión al antígeno o un derivado de los mismos y sus usos. Asimismo se proveen medios y métodos para diagnosticar, prevenir, aliviar y/o tratar una enfermedad, un trastorno y/o una anomalía asociada con agregados de TDP-43 que incluye, pero en un sentido no taxativo, demencia frontotemporal (FTD), esclerosis lateral amiotrófica (ALS), enfermedad de Alzheimer (AD), enfermedad de Parkinson (PD), encefalopatía traumática crónica, y encefalopatía TDP-43 con predominio límbico, relacionada con la edad (LATE).
ARP200101467A 2019-05-23 2020-05-22 Moléculas de unión anti-tdp-43 y usos de las mismas AR118999A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19176314 2019-05-23

Publications (1)

Publication Number Publication Date
AR118999A1 true AR118999A1 (es) 2021-11-17

Family

ID=66751870

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200101467A AR118999A1 (es) 2019-05-23 2020-05-22 Moléculas de unión anti-tdp-43 y usos de las mismas

Country Status (1)

Country Link
AR (1) AR118999A1 (es)

Similar Documents

Publication Publication Date Title
CL2021003027A1 (es) Moléculas de unión anti-tdp-43 y uso de las mismas.
Iram et al. Astrocytes from old Alzheimer's disease mice are impaired in Aβ uptake and in neuroprotection
BR112018000769A2 (pt) anticorpos específicos para tau hiperfosforilada e métodos para uso dos mesmos
Colonna et al. TREM2 variants: new keys to decipher Alzheimer disease pathogenesis
Krans et al. Neuropathology of RAN translation proteins in fragile X-associated tremor/ataxia syndrome
CY1123995T1 (el) Αντισωματα ειδικα για υπερφωσφορυλιωμενη ταυ και μεθοδοι χρησης αυτων
CL2023000907A1 (es) Anticuerpos de unión a gprc5d
Tian et al. Trimeric tau is toxic to human neuronal cells at low nanomolar concentrations
Rajbhandari et al. Toll‐like receptor 4 deficiency impairs microglial phagocytosis of degenerating axons
Miki et al. Accumulation of histone deacetylase 6, an aggresome‐related protein, is specific to Lewy bodies and glial cytoplasmic inclusions
CY1122987T1 (el) Αντισωματα εναντι αμυλοειδους βητα
EA201892362A1 (ru) Агонистические антитела, которые связываются с cd40 человека, и варианты их применения
BR112015022156A2 (pt) composições e métodos para modular a expressão de tau
Shukla et al. Sinomenine inhibits microglial activation by Aβ and confers neuroprotection
MX356800B (es) Anticuerpo tau humanizado.
Liu et al. Lymphocyte activation gene 3 (Lag3) expression is increased in prion infections but does not modify disease progression
CY1112337T1 (el) Καινοφανης ενωση αλφα-(ν-σουλφοναμιδο) ακεταμιδιου ως αναστολεας της παραγωγης του βητα αμυλοειδους πεπτιδιου
BR112012022102A2 (pt) polipeptídeos de ligação a a-beta.
CY1118046T1 (el) Πρωτεϊνες δεσμευσης με αντιγονο ειδικες για το συστατικο ρ αμυλοειδους ορου
BR112022012230A2 (pt) Variantes de progranulina
Müller-Schiffmann et al. Molecular engineering of a secreted, highly homogeneous, and neurotoxic Aβ dimer
BR112019000098A2 (pt) proteína de fornecimento ao cérebro, método de tratamento e/ou profilaxia de distúrbios cerebrais em mamíferos que possuem ou encontram-se em risco de desenvolver o mencionado distúrbio e método de diagnóstico e/ou detecção de distúrbios cerebrais em mamíferos suspeitos de possuir ou que se encontram em risco de desenvolver o mencionado distúrbio
MX2020006956A (es) Moleculas de union a tdp-43 mal plegadas.
Nakayama et al. Identification of linear polyubiquitin chain immunoreactivity in tau pathology of Alzheimer’s disease
BR112017020769A2 (pt) anticorpo ou fragmento de ligação, seq id no:3 ou seq id no:7, conjugado de anticorpo-fármaco (adc), composição farmacêutica, processo para produzir a composição farmacêutica, kit para diagnosticar um indivíduo que sofre de um distúrbio neurodegenerativo, método para diagnosticar um indivíduo que sofre de um distúrbio neurodegenerativo, uso do anticorpo ou fragmento de ligação, uso ex vivo de um peptídeo t14, método para identificar um agente candidato, ensaio para identificar um agente, método para identificar um agente que modula